Breast cancer is the most common malignancy and leading cause of cancer mortality in
women. Drug resistance is a major obstacle in systemic therapy of breast cancer, which …

ABSTRACT Preclinical Research Breast cancer is the most prevalent malignancy in women
with more than 1.3 million new cases every year worldwide. Chemotherapy is a critical …

With a high mortality rate that accounts for millions of cancer-related deaths each year,
breast cancer is the second most common malignancy in women. Chemotherapy has …

Breast cancer and specifically metastatic breast cancer (mBC) constitutes a major health
burden worldwide with the highest number of cancer-related mortality among women across …

Intrinsic or acquired resistance to commonly used therapeutic agents is a major challenge in
treating cancer patients. Decades of research have unraveled several unique and common …

MicroRNAs (miRNAs) are small non-coding RNA molecules that critically regulate the
expression of genes. MiRNAs are involved in physiological cellular processes; however …

MicroRNAs (miRNAs) are small noncoding RNA molecules with big implications in cancer.
The abnormal expression of specific miRNAs has been linked to development of many …

Studies with breast cancer cells, showed that microRNAs (miRNAs) act as regulators of
signaling pathways playing a key role in tumor progression and being targeted in …

Chemoresistance is one of the major hurdles to overcome for the successful treatment of
breast cancer. At present, there are several mechanisms proposed to explain drug …

Breast cancer (BC) formation is primarily influenced by genetics, epigenetics and
environmental factors. Aberrant Genetics and epigenetics leads to a condition known as …